Starpharma Holdings reported AUD20.28M in Cash and Equivalent for its fiscal semester ending in December of 2024.


Cash And Equivalent Change Date
Medical Developments International AUD 17.62M 7.88M Dec/2024
Mesoblast 62.56M 14.58M Jun/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024